Emergency pharmacy order.
Ended Awarded Last action
- Contract number
- 36C26025F0190
- Awardee
-
Insmed Incorporated UEI GLE1HZQ47JW6
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $10,105
Award facts
- Contract value 100% obligated
- $10,105.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Carrollton, TX 75010, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$60,632 | |
| Original award | $70,738 |
About this award
The Department of Veterans Affairs, Veterans Integrated Service Network 20, awarded a $10,105.40 delivery order to Insmed Inc. on March 21, 2025, for an emergency pharmacy order to be performed in Carrollton, Texas. This firm fixed-price delivery order, with an ultimate completion date of September 30, 2025, represents an urgent pharmaceutical supply need within the VA's healthcare network. The award was issued under Insmed's existing Multiple Award Federal Supply Schedule contract (FSS) for Pharmaceuticals and Drugs (Schedule 65 IB), valued at approximately $24.2 million and valid through May 2029. This GSA schedule vehicle enables the VA to procure critical medications across multiple medical centers and service networks, ensuring reliable access to specialized pharmaceutical products for veteran care.
Insmed Inc., a global biopharmaceutical company headquartered in Bridgewater, New Jersey, specializes in rare respiratory diseases and serves as a primary pharmaceutical supplier to the Department of Veterans Affairs. The contractor's federal portfolio with the VA includes multiple delivery orders for specialized medications, including ARIKAYCE (liposomal amikacin inhalation) and other critical treatments for complex medical conditions. This delivery order was not designated as a set-aside contract and represents one of several emergency and scheduled pharmaceutical supplies Insmed has provided to various Veterans Integrated Service Networks. The company maintains dual indefinite delivery vehicles with the VA National Acquisition Center: a Blanket Purchase Agreement valued at approximately $49,323 (effective through June 2026) and the aforementioned FSS contract, both supporting the VA's mission to deliver specialized medications to the veteran population.
Quick answers
Who was awarded contract 36C26025F0190?
36C26025F0190 was awarded to Insmed Incorporated by Veterans Integrated Service Network 20 (Veterans Health Administration) on March 21, 2025.
How much is contract 36C26025F0190 worth?
The government has obligated $10,105 on 36C26025F0190.
Is contract 36C26025F0190 an order under another contract?
Yes. 36C26025F0190 is a delivery order under 36F79724D0119, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26025F0190 competed?
The extent of competition for 36C26025F0190 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award